Pathogenic T‐Cell Recruitment into the Airway in Human Disease

Abstract: Effector T cells significantly contribute to inflammatory diseases. These cells are recruited into tissue, where they orchestrate an inflammatory response that can either protect against infection or sometimes stimulate human disease. The recruitment of T cells into tissue from the blood and lymphoid compartments is an active process controlled by chemokines and the chemokine receptors expressed on distinct effector T‐cell subsets. Thus, the chemokines secreted in the tissue will determine the specific types of T lymphocyte recruited into that tissue based on the chemokine receptors expressed on these cells. It follows that the chemokine receptor profile on T cells isolated from the lungs of patients with inflammatory pulmonary disease will define the subtype of pathogenic T lymphocytes mediating the disease process and will identify the mechanisms that recruit these cells into the lung. This article reviews data from both human and animal studies that define the chemokine receptors involved in the recruitment of T lymphocytes into the lung in various inflammatory pulmonary diseases, including asthma, obliterative bronchiolitis, sarcoidosis, and chronic eosinophilic pneumonia. We then speculate on the potential role of these chemokine receptors in the pathogenesis of these disorders and potential novel therapeutic approaches suggested by these data.

[1]  A. Morgan,et al.  Mechanisms of T cell migration to the lung , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  C. Power,et al.  Definition, function and pathophysiological significance of chemokine receptors. , 1998, Trends in pharmacological sciences.

[3]  L. Fabbri,et al.  The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. , 2001, The Journal of clinical investigation.

[4]  E. Miyazaki,et al.  Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. , 2002, American journal of respiratory and critical care medicine.

[5]  Marshall Hertz,et al.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  M. Estenne,et al.  Bronchiolitis obliterans after human lung transplantation. , 2002, American journal of respiratory and critical care medicine.

[7]  C. Agostini,et al.  New pathogenetic insights into the sarcoid granuloma. , 2000, Current opinion in rheumatology.

[8]  B. Medoff,et al.  IFN-γ-Inducible Protein 10 (CXCL10) Contributes to Airway Hyperreactivity and Airway Inflammation in a Mouse Model of Asthma1 , 2002, The Journal of Immunology.

[9]  K. Matsushima,et al.  Accumulation of CCR4‐expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia , 2003, Allergy.

[10]  R. Strieter,et al.  Th1 and Th2 responses regulate experimental lung granuloma development. , 1996, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[11]  H. Kita,et al.  Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. , 1996, The Journal of allergy and clinical immunology.

[12]  A. Matas,et al.  Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  A. Zeevi,et al.  Immunological monitoring of lung transplant patients by bronchoalveolar lavage analysis , 1992 .

[14]  E. Israel,et al.  Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. , 2001, American journal of respiratory and critical care medicine.

[15]  C. Agostini,et al.  Cells and Molecules Involved in the Development of Sarcoid Granuloma , 1998, Journal of Clinical Immunology.

[16]  J. Murray,et al.  Release of prostaglandin D2 into human airways during acute antigen challenge. , 1986, The New England journal of medicine.

[17]  M. Burdick,et al.  Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome1 , 2002, The Journal of Immunology.

[18]  James J. Campbell,et al.  Expression of Chemokine Receptors by Lung T Cells from Normal and Asthmatic Subjects1 , 2001, The Journal of Immunology.

[19]  L. Hassman,et al.  Pulmonary Chemokine Expression Is Coordinately Regulated by STAT1, STAT6, and IFN-γ , 2004, The Journal of Immunology.

[20]  E. Garrity,et al.  Prospective study of functional status and quality of life before and after lung transplantation. , 2000, Chest.

[21]  J. Wain,et al.  BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation , 2005, The Journal of experimental medicine.

[22]  T. Moore,et al.  Protection from Fluorescein Isothiocyanate-Induced Fibrosis in IL-13-Deficient, but Not IL-4-Deficient, Mice Results from Impaired Collagen Synthesis by Fibroblasts1 , 2004, The Journal of Immunology.

[23]  S. Lira,et al.  Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.

[24]  M. Epstein Do Mouse Models of Allergic Asthma Mimic Clinical Disease? , 2004, International Archives of Allergy and Immunology.

[25]  C. Herrick,et al.  To respond or not to respond: T cells in allergic asthma , 2003, Nature Reviews Immunology.

[26]  C. Mackay,et al.  The role of chemokine receptors in primary, effector, and memory immune responses. , 2000, Annual review of immunology.

[27]  Y. Liu,et al.  Immune Surveillance and Effector Functions of CCR10+ Skin Homing T Cells , 2002, The Journal of Immunology.

[28]  E. Walters,et al.  Bronchoalveolar Lavage (BAL) : Critical Evaluation of Techniques. , 2001, Methods in molecular medicine.

[29]  R. Rabin,et al.  CC-Chemokine Receptor 6 Is Expressed on Diverse Memory Subsets of T Cells and Determines Responsiveness to Macrophage Inflammatory Protein 3α , 1999, The Journal of Immunology.

[30]  M. Liu,et al.  Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. , 2003, The Journal of allergy and clinical immunology.

[31]  A. Tager,et al.  T-cell trafficking in asthma: lipid mediators grease the way , 2004, Nature Reviews Immunology.

[32]  D. Lamb,et al.  A type 2 (Th2‐like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA) , 1995, Clinical and experimental immunology.

[33]  C. Mackay,et al.  T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.

[34]  N. Lukacs Role of chemokines in the pathogenesis of asthma , 2001, Nature Reviews Immunology.

[35]  R. Braun,et al.  Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. , 1994, American journal of respiratory and critical care medicine.

[36]  Alan D. Roberts,et al.  Long-Term Maintenance of Virus-Specific Effector Memory CD8+ T Cells in the Lung Airways Depends on Proliferation1 , 2002, The Journal of Immunology.

[37]  J. Bradley,et al.  The T-cell requirements for allograft rejection* , 1992 .

[38]  S. Phan,et al.  Dual Roles of IL-4 in Lung Injury and Fibrosis1 , 2003, The Journal of Immunology.

[39]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[40]  T. Wynn,et al.  Global Gene Expression Profiles During Acute Pathogen-Induced Pulmonary Inflammation Reveal Divergent Roles for Th1 and Th2 Responses in Tissue Repair1 , 2003, The Journal of Immunology.

[41]  G. Trinchieri,et al.  Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. , 1996, Journal of immunology.

[42]  C. Brightling,et al.  The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. , 2005, American journal of respiratory and critical care medicine.

[43]  F. Re,et al.  Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells* , 2001, The Journal of Biological Chemistry.

[44]  W. Luttmann,et al.  Chemokine‐receptor expression on T cells in lung compartments of challenged asthmatic patients , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[45]  R. Fairchild,et al.  Chemokines: directing leukocyte infiltration into allografts. , 2002, Current opinion in immunology.

[46]  S. Bromley,et al.  Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics , 2005, Nature Immunology.

[47]  A. Zeevi,et al.  Propagation and characterization of lymphocytes from transplant biopsies. , 1991, Critical reviews in immunology.

[48]  S. Kohno,et al.  Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis. , 1997, Thorax.

[49]  F. Rea,et al.  Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. , 2001, The American journal of pathology.

[50]  L. Cosmi,et al.  CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease , 2000 .

[51]  A. Theofilopoulos,et al.  T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis. , 1996, The Journal of clinical investigation.

[52]  E. Trulock,et al.  Lung and Heart-Lung Transplantation: Overview of Results , 2001, Seminars in respiratory and critical care medicine.

[53]  J. Fredberg,et al.  Murine models of asthma , 2003, European Respiratory Journal.

[54]  M. Taniguchi,et al.  A clinical study of idiopathic eosinophilic pneumonia. , 1994, Chest.

[55]  J. Grunewald,et al.  Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis , 2003, Journal of internal medicine.

[56]  S. Durham,et al.  CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge , 2004, European Respiratory Journal.

[57]  R. Gerszten,et al.  Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment , 2003, Nature Immunology.

[58]  V. Kolek,et al.  Expression of Macrophage Inflammatory Protein-3β/CCL19 in Pulmonary Sarcoidosis , 2003 .

[59]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[60]  S. Orkin,et al.  A Critical Role for Eosinophils in Allergic Airways Remodeling , 2004, Science.

[61]  O. Yoshie,et al.  Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression , 2002, The Journal of Immunology.

[62]  G. Patterson,et al.  Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation , 1995 .

[63]  G. Berry,et al.  Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. , 1996, The Annals of thoracic surgery.

[64]  B. Beghé,et al.  Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis. , 2005, American journal of respiratory and critical care medicine.

[65]  S. Targan,et al.  The Role of Thymus-Expressed Chemokine and Its Receptor CCR9 on Lymphocytes in the Regional Specialization of the Mucosal Immune System1 , 2000, The Journal of Immunology.

[66]  S. Lira,et al.  Attenuation of Allergen-Induced Responses in CCR6−/− Mice Is Dependent upon Altered Pulmonary T Lymphocyte Activation , 2005, The Journal of Immunology.

[67]  S. Kunkel,et al.  Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4‐/‐ mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  J. Lafitte,et al.  Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. , 2001, The Journal of allergy and clinical immunology.

[69]  Tong-Yuan Yang,et al.  Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice , 2001, The Journal of experimental medicine.

[70]  P. Libby,et al.  Differential Expression of the IFN-γ-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell α Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection1 , 2002, The Journal of Immunology.

[71]  Eric J. Kunkel,et al.  CCR7 Expression and Memory T Cell Diversity in Humans1 , 2001, The Journal of Immunology.

[72]  H. Mukae,et al.  Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. , 2000, The Journal of allergy and clinical immunology.

[73]  R. Puri,et al.  Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells 1 , 2003, The Journal of Immunology.

[74]  D. D'Ambrosio,et al.  Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. , 2001, American journal of respiratory and critical care medicine.

[75]  M. Baggiolini,et al.  Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes , 1996, The Journal of experimental medicine.

[76]  E. Chi,et al.  The importance of leukotrienes in airway inflammation in a mouse model of asthma , 1996, The Journal of experimental medicine.

[77]  J. Virchow,et al.  T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. , 1995, American journal of respiratory and critical care medicine.

[78]  C. Mackay,et al.  Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.

[79]  B. Damaj,et al.  Expression and regulation of chemokine receptors in human natural killer cells. , 2001, Blood.

[80]  C. Mackay,et al.  Expression of monocyte chemoattractant protein‐1 and interleukin‐8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential , 1996, European journal of immunology.

[81]  A. Wade,et al.  Lung transplantation and life extension in children with cystic fibrosis , 1999, The Lancet.

[82]  C. Caux,et al.  Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites , 1998, The Journal of experimental medicine.

[83]  L. Cauley,et al.  Antiviral memory T-cell responses in the lung. , 2002, Microbes and infection.

[84]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[85]  R. Crystal,et al.  Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. , 1985, The Journal of clinical investigation.

[86]  M. Chilosi,et al.  Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. , 1998, Journal of immunology.

[87]  Y. Kaneda,et al.  Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[88]  A. Waaga,et al.  Mechanisms of chronic rejection. , 2000, Current opinion in immunology.

[89]  B. Griffith,et al.  Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. , 1990, Transplantation.

[90]  H. Soto,et al.  CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.

[91]  T. Out,et al.  Influx of Neutrophils into the Airway Lumen at 4 h after Segmental Allergen Challenge in Asthma , 1999, International Archives of Allergy and Immunology.

[92]  E. Kunkel,et al.  Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. , 2001, The Journal of clinical investigation.

[93]  Stuart B. Goodman,et al.  Lymphocyte Cc Chemokine Receptor 9 and Epithelial Thymus-Expressed Chemokine (Teck) Expression Distinguish the Small Intestinal Immune Compartment , 2000, The Journal of experimental medicine.

[94]  James J. Campbell,et al.  The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells , 1999, Nature.

[95]  Sharon Engel,et al.  A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.

[96]  S. Tullius,et al.  Both alloantigen-dependent and -independent factors influence chronic allograft rejection. , 1995, Transplantation.

[97]  H. Mukae,et al.  Interleukin 5 and granulocyte-macrophage colony-stimulating factor levels in bronchoalveolar lavage fluid in interstitial lung disease. , 2000, The European respiratory journal.

[98]  E. Kriehuber,et al.  Macrophage Inflammatory Protein 3α Is Involved in the Constitutive Trafficking of Epidermal Langerhans Cells , 1999, The Journal of experimental medicine.

[99]  D. Adams,et al.  Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. , 2001, Transplantation.

[100]  A. Tager,et al.  Signal Transducer and Activator of Transcription 6 Controls Chemokine Production and T Helper Cell Type 2 Cell Trafficking in Allergic Pulmonary Inflammation , 2001, The Journal of experimental medicine.

[101]  M. Fujimura,et al.  Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia. , 1998, Respiratory medicine.

[102]  M. Essink‐bot,et al.  The effect of lung transplantation on health-related quality of life: a longitudinal study. , 1998, Chest.